A technique for relative quantitation of cancer biomarkers in formalin-fixed, paraffin-embedded (FFPE) tissue using stable-isotope-label based mass spectrometry imaging (SILMSI)

Distribution of estrogen and progesterone receptors isoforms in endometrial cancer

(2014) Hila Kreizman-Shefer et al.   Diagnostic Pathology

Multiplexed immunohistochemistry, imaging, and quantitation: A review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis

(2014) Edward C. Stack et al.   METHODS

Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer

(2012) Stephan Meding et al.   JOURNAL OF PATHOLOGY

Tumor Classification of Six Common Cancer Types Based on Proteomic Profiling by MALDI Imaging

(2012) Stephan Meding et al.   JOURNAL OF PROTEOME RESEARCH

EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

(2012) Ryan B. Corcoran et al.   Cancer Discovery

MALDI Imaging Identifies Prognostic Seven-Protein Signature of Novel Tissue Markers in Intestinal-Type Gastric Cancer

(2011) Benjamin Balluff et al.   AMERICAN JOURNAL OF PATHOLOGY

MALDI tissue imaging: from biomarker discovery to clinical applications

(2011) Lisa H. Cazares et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

MALDI Imaging Mass Spectrometry (MALDI-IMS)―Application of Spatial Proteomics for Ovarian Cancer Classification and Diagnosis

(2011) Johan O. R. Gustafsson et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

(2011) John M.S. Bartlett et al.   JOURNAL OF CLINICAL ONCOLOGY

Mass spectrometry imaging for drugs and metabolites

(2011) Tyler Greer et al.   Journal of Proteomics

4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors

(2010) Qing-Bai She et al.   CANCER CELL

Classification of HER2 Receptor Status in Breast Cancer Tissues by MALDI Imaging Mass Spectrometry

(2010) Sandra Rauser et al.   JOURNAL OF PROTEOME RESEARCH

Liquid ionic matrixes for MALDI mass spectrometry imaging of lipids

(2010) Céline Meriaux et al.   Journal of Proteomics

Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999-2004

(2009) Carol A. Parise et al.   Breast Journal

Antibody Elution Method for Multiple Immunohistochemistry on Primary Antibodies Raised in the Same Species and of the Same Subtype

(2009) Daniel Pirici et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

MALDI Imaging Mass Spectrometry

(2009) Julien Franck et al.   MOLECULAR & CELLULAR PROTEOMICS

Basal vs. luminal a breast cancer subtypes: a matched case-control study using estrogen receptor, progesterone receptor, and HER-2 as surrogate markers

(2008) Ezzeldin Ibrahim et al.   MEDICAL ONCOLOGY